CYP cynata therapeutics limited

9.68%

17.0¢

why is it so "interesting" (poor shade throwing attempt) if you...

First 14 Last

Share
Profile

Follow
Sector

35,472 Posts.

2863

16/11/22

20:16

Post #: 64817515
Share

Originally posted by Bazsa: ↑

"More Predictable"

Thats a intersting comment.

So why is there no undisputable data , after all if the cells were predictable it should be easy to prove benifit. But no clinical benifit has been shown after 150 patients been treated. That would indicate ether the cells do not work or they do but only in a very small population that remain unknown.

DFU The only conclution one can make is that the cells seem safe , I would be surprised if the DSMB were tasked to look at efficacy.

I was surprised at the progress made with the OA trial however if it is allowed to run its full length resaults will remain unknown till mid 26- 27. The half way point is now very close and this could triger a review by the DSMB. The recomendation to continue as planed would be a very big relief to the market as the outcome is at a pivotal point. But what if they stoped the trial? A single didget SP while investors hope for a more positive outcome for DFU.

Expand

why is it so "interesting" (poor shade throwing attempt) if you read it with all the other comments?

Best you contact Monash University Bazzar.
No one here listens to you Baz (bar other shade throwers) after your woeful track record of misinformation, busted time and time again.
you know it
and your MO is to disappear until the next schooling

Last edited by Sector: 16/11/22

CYP Price at posting: 35.0¢ Sentiment: Buy Disclosure: Held
4 Upvote

1 Great analysis

Reply

Top Stories

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

AII

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

First 14 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 17.0¢		Change 0.015(9.68%)		Mkt cap ! $38.41M

Open	High	Low	Value	Volume
15.5¢	17.0¢	15.5¢	$47.10K	289.1K

Buyers (Bids)

No.	Vol.	Price($)
1	50000	16.5¢

Sellers (Offers)

Price($)	Vol.	No.
17.0¢	23813	3

View Market Depth

No.	Vol.	Price($)
1	50000	0.165
4	47240	0.155
4	161673	0.150
1	5000	0.145
2	45000	0.140

Price($)	Vol.	No.
0.170	18813	2
0.175	55250	1
0.180	62619	3
0.185	35990	1
0.195	19300	1

Last trade - 16.10pm 27/06/2025 (20 minute delay)

CYP (ASX) Chart

why is it so "interesting" (poor shade throwing attempt) if you...

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Australia’s gas crisis is here – and dying coal plants aren’t helping

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Monash IVF shares cater 25% – Disaster or deep-value play?

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

why is it so "interesting" (poor shade throwing attempt) if you...

Top Stories

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Australia’s gas crisis is here – and dying coal plants aren’t helping

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Monash IVF shares cater 25% – Disaster or deep-value play?

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News